Pharma Journalist -

SMi Reports: Exclusive interview with Cedric Gysel from Johnson and Johnson ahead of the 12th annual Pre-Filled Syringe and Injectable Drug Devices conference being held in London on…
Read More...

PDS Biotechnology Corporation announced that it has completed manufacturing of clinical batches of PDS0101 with its partner BSP Pharmaceuticals S.p.A, a leading manufacturer of…
Read More...

Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients,…
Read More...

Zealand Pharma A/S, a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, announces the acquisition of Encycle…
Read More...

Takeda Pharmaceutical Company Limited and COUR Pharmaceutical Development Company, Inc. announced that Takeda has acquired an exclusive global license to develop and commercialize the…
Read More...

Biogen and Eisai, Co., Ltd. announced that, after consulting with the U.S. Food and Drug Administration (FDA), Biogen plans to pursue regulatory approval for aducanumab, an…
Read More...

Bryn Pharma announced that it has entered into an agreement with Aptar Pharma, a leading drug delivery systems provider, for the supply and worldwide exclusive right to use Aptar's…
Read More...

Moberg Pharma AB has signed a distribution agreement with DongKoo Bio & Pharma Co., Ltd for MOB-015 in the Republic of Korea. Under the agreement DongKoo is granted exclusive rights…
Read More...

Odonate Therapeutics, a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer, today announced the…
Read More...

Knight Therapeutics Inc. announced that it has entered into a definitive agreement under which Knight will acquire a 51.21% interest in Biotoscana Investments S.A. (B3: GBIO33) from a…
Read More...